VSEE HEALTH, INC.
Close on Oct 1, 2026
- Market cap
- $112.85M
- P/E (TTM)
- –
- Dividend yield
- –
About Vsee Health
Services-Health Services, SIC 8000
VSee Health, Inc. provides digital healthcare and telehealth technology solutions designed to facilitate patient engagement, clinical coordination, and critical care delivery. Through its subsidiary VSee Lab, the company offers a modular, no-code and low-code telehealth software platform featuring tools for virtual patient visits, appointment scheduling, intake management, remote medical examinations, and remote patient monitoring. Through its subsidiary iDoc, the company delivers specialized tele-intensive care and virtual specialist staffing services, including neurocritical, cardiac, and pulmonary critical care coverage, as well as electronic consultations across numerous medical specialties. Its primary customers include health systems, large and small hospitals, long-term acute care facilities, and the Federal Bureau of Prisons.
The company operates primarily within the United States, serving diverse healthcare enterprises ranging from academic medical centers to micro-hospitals and federal correctional facilities. VSee Health maintains its principal executive offices in Boca Raton, Florida.
Summary of the business section of Vsee Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- VSEE HEALTH, INC.
- Headquarters
- Boca Raton, FL
- Address
- 980 N Federal Hwy, #304 33432
- Phone
- (561) 672-7068
- Employees
- 209, Dec 31, 2025
- Industry
- Services-Health Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- WWC, P.C., San Mateo, California
Stock & identifiers
- Ticker
- VSEE
- Other tickers
- VSEED, VSEEW
- IPO date
- Nov 4, 2021
- Shares outstanding
- 57M, Aug 12, 2026
- Public float
- $18.17M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-80 reverse, Sep 24, 2026
- SEC CIK
- 1864531
- CUSIP
- 92919Y110
- ISIN
- US92919Y1102
- EIN
- 86-2970927
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Milton Chen | Co-Chief Executive Officer, Director | 0 |
| Imoigele Aisiku | Co-Chief Executive Officer, Director | 3,338,000 |
| Jerry Leonard | Chief Financial Officer | 603,109 |
| Scott Metzger | Director | 117,356 |
| Colin P. O'Sullivan | Director | 108,731 |
| David L. Wickersham | Director | 2,335,235 |
| Kevin Lowdermilk | Director | 108,731 |
| Cydonii V. Fairfax | Director | 108,504 |
Employees
Headcount reported in annual reports
“We currently have approximately 209 full-time equivalent employees and contractors, of which approximately 93 are board certified practicing physicians.”
Corporate history
Events identified from SEC filings